Giuseppe Mazza

Dr Giuseppe Mazza co-founded Engitix and has served as Chief Executive Officer (CEO) since the Company’s formation in 2016.

Engitix is built on Dr Mazza’s pioneering research, where he developed novel decellularisation procedures for human tissues, including whole livers, while working in the laboratory of Professor Massimo Pinzani at the Institute for Liver and Digestive Health (IDLH), Division of Medicine, University College London (UCL).

Dr Mazza was a Post-Doctoral Fellow at the UCL IDLH, where he was also responsible for operating the Tissue Engineering and Regenerative Medicine Laboratory. Dr Mazza received his PhD in Tissue Engineering and Organ Regeneration from UCL. Dr Mazza was Director R&D at Promethera Bioscience from 2015 to 2017.

He has been involved in several international healthcare organizations, including serving on the Steering Committee of the non-profit European Haemophilia Consortium (EHC). In 2011, he founded the healthcare charity Associazione Icore ONLUS, where he served as President for six years.